Within cranio-maxillofacial surgery and orthopedic surgery a bone graf
t or a bone substitute is required to recontour or assist bony healing
in repair of osseous congenital deformities, or in repair of deformit
y due to trauma or to surgical excision after elimination of osseous d
isease processes exceeding a certain size. An autogenous bone graft is
the optimal material of choice, however its use is problematic due to
donor site morbidity, sparse amounts and uncontrolled resorption. Imm
unological responses and risk of viral contamination of allogenous and
xenogenous bone materials make the use of these materials questionabl
e. Healing and degradation of alloplastic materials are inconsistent w
ith subsequent restricted use. The principle of guided tissue regenera
tion excluding soft tissue cells from a certain area is not alone suff
icient to insure complete bony healing. Recombinant bone morphogenetic
proteins have with success been added as adjuncts to already known bi
omaterials. In the future, inductive materials together with a suitabl
e carrier and a biodegradable membrane may be the choice of bone subst
itute used within cranio-maxillofacial and orthopaedic surgery.